```html

Wine‑Colored Urine: What It Means and What to Do About It

What is Wine-colored urine?

Wine-colored urine is a term used to describe a dark, reddish‑brown hue that resembles red wine, port, or grape juice. The color change is usually caused by the presence of pigments, blood, or certain metabolites in the urinary tract. While occasional dark urine can be harmless—often related to dehydration or diet—persistent or repeatedly dark urine may signal an underlying medical condition that requires evaluation.

Understanding the exact cause is essential because the color alone does not pinpoint a diagnosis; it is a clue that must be interpreted in the context of other symptoms, medical history, and laboratory results.

Common Causes

Below are the most frequent conditions and factors that can produce wine‑colored urine. Some are benign, while others are potentially serious.

• Hematuria (blood in the urine) – can be microscopic or visible; caused by kidney stones, infection, trauma, or tumors.
• Rhabdomyolysis – breakdown of muscle tissue releases myoglobin, a pigment that darkens urine; often linked to severe exertion, crush injuries, or certain medications.
• Porphyria – a group of rare metabolic disorders that affect heme synthesis; excess porphobilinogen and porphyrins may turn urine a deep red or brown.
• Benign or malignant melanoma metastasis – melanin released from tumor cells can pigment the urine.
• Medication‑induced discoloration – drugs such as rifampin, metronidazole, nitrofurantoin, chloroquine, and some antiretrovirals (e.g., atazanavir) can color urine.
• Food and beverages – beetroot, blackberries, rhubarb, and large amounts of red wine or food dyes may temporarily tint urine.
• Hemolytic anemia – accelerated destruction of red blood cells releases hemoglobin that can darken urine.
• Kidney disease – glomerulonephritis or interstitial nephritis can cause hematuria and protein leakage, giving urine a darker hue.
• Urinary tract infection (UTI) – especially with bleeding or presence of certain bacteria that produce pigments.
• Severe dehydration – concentrated urine appears darker; while not truly “wine‑colored,” it can be mistaken for it.

Associated Symptoms

The presence of additional signs helps clinicians narrow down the cause. Common accompanying symptoms include:

• Pain or burning during urination (dysuria)
• Flank or lower‑abdominal pain
• Fever, chills, or malaise
• Visible blood clots in the urine
• Swelling of the legs or ankles (edema)
• Muscle weakness, cramps, or swelling (indicative of rhabdomyolysis)
• Jaundice or yellowing of the skin (suggesting hemolysis or liver involvement)
• Unexplained weight loss or night sweats (possible malignancy)
• Skin rash or photosensitivity (seen in some porphyrias)
• Recent use of new medications, supplements, or excessive intake of colored foods

When to See a Doctor

Although occasional dark urine is often benign, you should schedule a medical evaluation promptly if any of the following occur:

• The dark color persists for more than 24‑48 hours.
• You notice blood clots, a strong odor, or foaminess in the urine.
• Pain is present in the back, side, lower abdomen, or genital area.
• You develop fever, chills, or a feeling of being “very ill.”
• There is swelling of the legs, face, or hands.
• You experience muscle pain, weakness, or dark “tea‑colored” urine after strenuous activity.
• You have a personal or family history of kidney stones, kidney disease, or cancer.
• You are pregnant or have known chronic health conditions (diabetes, hypertension, autoimmune disease).

Diagnosis

Doctors use a step‑wise approach that combines patient history, physical examination, and targeted tests.

1. Detailed History

• Duration and pattern of urine discoloration.
• Recent illnesses, injuries, surgeries, or intense exercise.
• Medication, supplement, and dietary intake (including foods that may color urine).
• Associated symptoms listed above.
• Family history of kidney disease, blood disorders, or cancers.

2. Physical Examination

• Check for flank tenderness, abdominal masses, or skin changes.
• Assess for signs of dehydration, edema, or jaundice.

3. Laboratory Tests

• Urinalysis – dipstick for blood, protein, leukocytes; microscopic exam for red cells, casts, and crystals.
• Urine culture – if infection is suspected.
• Serum creatinine & BUN – evaluate kidney function.
• Complete blood count (CBC) – looks for anemia, infection, or hemolysis.
• Creatine kinase (CK) – markedly elevated in rhabdomyolysis.
• Serum electrolytes – especially potassium and calcium, which may be disturbed in muscle breakdown.
• Hemolysis panel (LDH, haptoglobin, bilirubin) if hemolytic anemia is considered.
• Porphyrin studies – urine or blood porphyrin levels for suspected porphyria.

4. Imaging

• Ultrasound – first‑line to detect stones, hydronephrosis, or masses.
• CT scan of abdomen/pelvis – higher sensitivity for stones, tumors, or traumatic injury.
• MRI – used for soft‑tissue evaluation when cancer is suspected.

5. Specialized Tests

• Kidney biopsy – rarely needed but may be performed for unexplained glomerulonephritis.
• Genetic testing – for hereditary porphyrias or rare metabolic disorders.

Treatment Options

Treatment is directed at the underlying cause. General measures that support kidney health apply to most situations.

General Supportive Care

• Hydration – drinking adequate fluids (≥2 L/day for most adults) dilutes urine and helps flush out pigments or blood.
• Avoid nephrotoxic agents – e.g., non‑steroidal anti‑inflammatory drugs (NSAIDs), excessive alcohol, and certain contrast dyes unless medically necessary.
• Monitor urine output; aim for >0.5 mL/kg/hr.

Condition‑Specific Treatments

• Hematuria from stones or infection – antibiotics for infection; lithotripsy, ureteroscopy, or surgical removal for stones.
• Rhabdomyolysis – aggressive IV fluid resuscitation (often 200–300 mL/hr); alkalinization of urine with bicarbonate in severe cases; monitor electrolytes and renal function.
• Porphyria – avoid triggering substances (certain drugs, fasting, sunlight); provide hemin infusions and carbohydrate loading during acute attacks.
• Medication‑induced discoloration – discontinue or switch offending drug under physician guidance.
• Melanoma metastasis – oncologic management (surgery, immunotherapy, targeted therapy).
• Kidney disease – disease‑specific interventions (immunosuppression for glomerulonephritis, blood pressure control, dietary protein restriction).
• Hemolytic anemia – treat underlying cause (immune suppression, vitamin B12/folate supplementation, transfusion if needed).

Prevention Tips

• Stay well‑hydrated, especially during hot weather, illness, or high‑intensity exercise.
• Maintain a balanced diet rich in fruits and vegetables but moderate in foods that can naturally color urine (beets, blackberries).
• Use medications only as prescribed; discuss potential urine‑color side effects with your pharmacist or physician.
• Practice safe exercise habits—gradual warm‑up, proper conditioning, and adequate rest to avoid muscle breakdown.
• Manage chronic conditions (diabetes, hypertension) to protect kidney function.
• For individuals with known porphyria, keep a list of safe medications and avoid fasting or extreme dieting.
• Regularly screen for kidney stones if you have a personal or family history (urine citrate, calcium, and oxalate monitoring).

Emergency Warning Signs

Bottom Line

Wine-colored urine can be a benign, temporary change or a warning sign of a serious medical condition. Paying attention to accompanying symptoms, staying hydrated, and seeking timely medical evaluation are key steps. Early diagnosis—whether it’s an infection, kidney stone, rhabdomyolysis, or a rarer metabolic disorder—greatly improves outcomes.

References:

• Mayo Clinic. “Hematuria.” https://www.mayoclinic.org
• National Institutes of Health (NIH). “Rhabdomyolysis.” https://www.nhlbi.nih.gov
• Cleveland Clinic. “Porphyria.” https://my.clevelandclinic.org
• CDC. “Urinary Tract Infection (UTI) Treatment.” https://www.cdc.gov
• World Health Organization. “Guidelines for Safe Use of Medications.” https://www.who.int

```